Approval of the HSC on our products f...

As a manufacturer of BIOCREDIT COVID-19 Ag – Nasopharyngeal or Nasal, Rapigen Inc. hereby declares that: The Health Security Committee agreed on the EU common list of both BIOCREDIT COVID-19 Ag ...

2022.10.24

Celebrating Rapigen’s 20th Anniversary

To mark this historic milestone, Rapigen Head Office in Suwon factory hosted a special event to celebrate its 20th anniversary with Rapigen’s family members. Featured activities included a specia...

2022.06.17

Rapigen to work with Eunpyeong St. Ma...

Rapigen and Eunpyeong St. Mary’s Hospital pose for a photo after signing a business agreement for joint research and development on Medical devices for In-Vitro Diagnosis in preparation for pos...

2022.05.12

Authorization given to add Rapigen’s ...

The BIOCREDIT COVID-19 Ag Home Test met the selection criteria and was forwarded for full evaluation by Science and Technical Advisory.Upon full evaluation, the BIOCREDIT COVID-19 Ag Home Test ...

2022.03.16